Short-Term, High-Dose Atorvastatin Pretreatment to Prevent Contrast-Induced Nephropathy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the ARMYDA-CIN [Atorvastatin for Reduction of MYocardial Damage during Angioplasty–Contrast-Induced Nephropathy] Trial

Patti, Giuseppe, MD ; Ricottini, Elisabetta, MD ; Nusca, Annunziata, MD ; Colonna, Giuseppe, MD ; Pasceri, Vincenzo, MD ; D'Ambrosio, Andrea, MD ; Montinaro, Antonio, MD ; Di Sciascio, Germano, MD

The American journal of cardiology, 2011-07, Vol.108 (1), p.1-7 [Periódico revisado por pares]

New York, NY: Elsevier Inc

Texto completo disponível